Kura Oncology Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6,232.3% | -20.0% | +37.3% | +90.3% | +32.7% | +167.5% | -17.5% | -14.6% | -1.6% | +69.3% | -2.9% | |
| – | +7,163.3% | -20.8% | +37.5% | +91.5% | +32.2% | +166.0% | -18.0% | -14.5% | -3.1% | +72.2% | -4.9% | |
| – | +1,273.9% | -37.0% | +17.6% | +41.0% | +62.1% | +1,145.4% | -72.1% | -42.9% | -28.0% | +501.5% | -33.6% | |
| – | +7,528.6% | -20.9% | +37.4% | +92.2% | +32.4% | +167.3% | -18.2% | -15.4% | -3.2% | +71.6% | -8.3% | |
| – | +1,333.3% | -31.4% | -26.8% | +3.7% | -86.6% | – | – | -35.7% | +211.1% | +117.9% | +106.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +163.0% | -43.7% | -75.0% | – | – | +627.0% | +32.3% | -5.0% | – | – | – | |
| – | +7.2% | +151.1% | +23.5% | +33.8% | +8.4% | +56.6% | -24.4% | +31.3% | +43.4% | +570.7% | +62.8% | |
| – | +67.6% | +7.8% | +84.0% | +35.7% | +14.3% | +67.2% | -13.7% | +7.1% | +46.6% | +123.2% | +48.6% | |
| – | – | – | -79.1% | – | – | +913.7% | -55.5% | +2.4% | -35.0% | +198.0% | -71.5% | |
| – | +310.6% | +51.7% | -11.4% | +215.3% | -10.4% | -21.9% | +17.5% | -52.6% | +50.0% | -36.1% | +241.5% | |
| – | +1,385.6% | +0.0% | -24.0% | +34.7% | -3.3% | -41.4% | – | – | +1.9% | -25.9% | +40.4% | |
| – | – | -30.7% | +40.4% | +101.6% | +35.9% | +179.2% | -17.1% | -17.0% | -5.5% | +4.1% | -57.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +142.7% | +88.3% | +24.3% | +51.4% | +19.2% | +26.5% | +25.0% | +1.0% | +9.3% | +17.7% | +1.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.